| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |